We debuted a new scan recently- The Outperformers.

The Outperformers is our newest scan that pinpoints the very best stocks in the market. It’s the fastest, easiest way to find quality names that are primed for major moves.

The goal is that as the market rally progresses, the sector rotation within the market will reflect in this scan. So while our Top/Down Analysis helps us with the broader view of the market, this Bottom/Up scan makes sure that we catch the slightest change in sentiment.

From the desk of Steve Strazza @Sstrazza

"There's no such thing as a free lunch."

Many of you are already familiar with this popular market adage as it is a commonly used quip in our industry.

All it really means is that you can't get something for nothing from the market.

Have you ever bought a high-yielding stock for the dividend and rode it into a big drawdown just for them to announce they're cutting the payout?

Did you listen to a friend about a biotech stock that was supposed to rip higher on positive FDA results... but it actually gapped lower?

How about following the analyst community into a stock that was a consensus buy... until it turned out not to be?

In all of these scenarios, the investor is simply looking for a free lunch. And 9 times out of 10, these situations don't work out. There are no easy investments or get-rich-quick tricks on wall street. At least not sustainable ones. You have to put in the work.

One rule that I live by for my own investing is this: "If it seems too good to be true, it probably is."

I've learned first-hand to run from investment opportunities that don't...

Some stocks are just built different.

Right now it's hard to ignore how the bond market is impacting certain stocks, and which ones of those are already ahead of the game.

You see in December, we've seen credit spreads narrowing to levels not seen since the pandemic crash in 2020. The Yield curve has been steepening as well. And rates in general, particularly the 10yr and 30yr held their key levels and started moving higher.

To me, all of this screams higher for bank stocks. But it's not a one size fits all scenario. There are leaders.

And I can't help but point out Customers Bancorp. This $2B Regional Bank stock has continued to make new all-time highs, despite the industry under pressure over the past couple of months.

This is the video recording of our December 29, 2021, All Star Charts Crypto Weekly Strategy Session.

We’re buying an $MPC Feb/Apr 70 Call Calendar Spread for around a $1.10 debit. This means we’ll be short the February 70 calls and long an equal amount of April 70 calls for a net debit

Check out our short video with the thought process behind these trades:

From the desk of Steve Strazza @Sstrazza

When investing in the stock market, we always want to approach it as a market of stocks.

Regardless of the environment, there are always stocks showing leadership and trending higher.

We may have to look harder to identify them depending on current market conditions… but there are always stocks that are going up.

The same can be said for weak stocks. Regardless of the environment, there are always stocks that are going down, too. 

We already have multiple scans focusing on stocks making all-time highs, such as Hall of Famers, Minor Leaguers, and the 2 to 100 Club. We filter these universes for stocks that are exhibiting the best momentum and relative strength characteristics. 

The point is that we spend a lot of time identifying and writing about leading stocks every week, via multiple reports. Now, we’re also highlighting lagging stocks on a recurring basis.

From the desk of Steve Strazza @Sstrazza and Ian Culley @Ianculley

With the exception of US large-caps, the market remains range-bound for most risk assets. At the same time, most defensive assets are failing to catch any meaningful bid.

Gold is still chopping around in the middle of its year-to-date range. Bonds continue to trend sideways or lower. The Japanese yen recently hit its lowest level since 2017. 

And while the defensive sectors recently made multi-month highs versus the broader market, they're still trading near 20-year lows on a relative basis.

These are the kinds of assets we expect to catch a bid in an environment where investors are fleeing for safety and positioning defensively. But we’re just not seeing that.

At the same time, we haven’t seen many definitive signals supporting a more risk-on tone… until now!

While our risk-appetite ratios remain a mixed bag and most are simply range-bound, we just got a meaningful upside resolution in the High Yield versus Treasuries ratio.

The ratio of high-yield corporate bonds versus US Treasuries has been consolidating beneath a critical level of...

I'll spare you the suspense -- we're getting long Marathon Petroleum $MPC here.

The title of today's post is not a trite pun. We are indeed positioning for a bullish move, but it may take a little bit to develop the way we want it to.

Thankfully, the beauty of options trading is that we can craft a strategy that takes advantage of a slow-developing play. So let's get right to it.

We've been talking about how the major strength in the current market has been coming through in IT. But what we also noticed is that while Nifty Pharma wasn't looking pretty on an absolute basis, the relative strength is pointing in a different direction.

Pharma has been gaining our attention for the past few weeks. This post will see if broad participation is back in Pharma or just a few value weightage stocks are gaining higher.

It's important to zoom out and really put what's going on into perspective.

You hear a lot about how much money is being created with fed money printing and the Powell and senator Karen yelling into the air for no reason.

It's all been well documented.

We're seeing unprecedented numbers being raised by companies issuing equity and debt, as highlighted here by the FT:

From the desk of Steven Strazza @Sstrazza and Ian Culley @IanCulley

As 2022 approaches, the latest evidence from currency markets suggest the US Dollar Index $DXY could be stalling out.

Whether it resolves higher from the current continuation pattern is a key question with broad market implications. While dollar strength has been a headwind during the second half of 2021, we think it cools off coming into 2022.

In our view, there's a good chance a weaker dollar will actually help put a bid in risk assets in the near future. This hasn’t been the case in a while, so let’s discuss what’s changed to make us feel this way.

Notice the short-term weakness in our US dollar trend summary table:

The percentage of short-term bearish readings has jumped from 13.37 to 60.00 over the past two weeks. This tells us there's been a significant drop-off in the dollar’s strength versus its peers, even as the DXY coils in a tight bull flag.

Bulls want to see the dollar get stronger beneath the surface to support a resolution...

Register here for our live monthly conference call for Premium Members of All Star Charts India.

January's Strategy Session will be held on Tuesday, January 4th at 7 PM IST. As always, if you cannot make the call live, the video and slides will be archived and published here along with all of our past conference calls.

Here are the details for Tuesday: